Dublin, Jan. 26, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/xs4hnp/autoinjectors_to) has announced the addition of the "Autoinjectors to 2024" report to their offering.
Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the introduction and evolution of autoinjectors - devices that are designed to accept a standard prefilled syringe and form an outer user-friendly device package that simplifies the injection process. Autoinjectors enable a significantly larger segment of the patient population to self-administer injectables. This report analyzes eleven important therapeutic segments and examines the impact of autoinjectors on injectable drug markets.
What You Will Learn
- What autoinjectors can be paired with prefilled syringes for injectable drug delivery; what are the key market segments, market dynamics and market demographics?
- What are the therapeutic demand drivers and commercial devices in key product segments?
- What are the design factors, material selection issues, technologies and market development issues?
- How big is the market? How is it growing? What will it look like in 2024?
- Who are the leading injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations?
- What is the importance of pharma-device alliances and design partnerships on autoinjector commercialization and market access?
- What is the impact of wirelessly connected autoinjectors on patient care and market growth?
- What are the significant economic, technology, and regulatory factors affecting the market for autoinjectors?
Key Topics Covered:
1. Executive Summary
2. The Market Opportunity
3. Delivery Market Dynamics
- The Economics of Injectable Drugs
- What's Driving the Growth in Autoinjectors?
- Prefilled Devices Proliferating
- The Trend toward Self-Administration
- Shifting Demographics
- Innovation in Disposable Device Designs
- Therapeutic Demand Drivers
- Competitive Landscape
- Risk Factors
4. Autoinjectors - Commercial Devices
- Manual Injection Autoinjectors
- Automated Injection Autoinjectors
- Reusable Autoinjectors
- Disposable Autoinjectors
- Variable Dose Autoinjectors
- Smart Autoinjectors
- Product Specific Autoinjectors
5. Autoinjector Device Design Factors
- Material Selection Issues
- Part Counts and Device Cost
- Safety Features
- Needle Insertion Depth
- Dose Inspection/Injection Confirmation
- Wireless Connectivity
- Lyophilized Drugs/Reconstitution
- Human Engineering/Ergonomics
6. Autoinjector Drug Delivery - Therapeutic Sector Analysis
- Anaphylaxis/Countermeasures
- Anticoagulants
- Autoimmune Diseases
- Emergency Medicine
- Infectious Diseases
- Hematopoietics
- Hormones
- Neurology
- Reproductive Health
7. Market Factors
- Regulatory Issues
- Device Branding
- Patient Compliance and Ease of Use
- Healthcare Economics
8. Company Profiles
For more information visit http://www.researchandmarkets.com/research/xs4hnp/autoinjectors_to
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Washington Post Publisher Will Lewis Steps Down After Layoffs 



